Lauri Burroughs

Lauri Burroughs, MD is a Professor in the Clinical Research Division at Fred Hutchinson Cancer Center and Professor of Pediatrics at the University of Washington. She serves as Director of the Non-Malignant Transplant Program at Seattle Children's Hospital / Fred Hutch, leading clinical and research initiatives for pediatric noncancerous blood disorders.

Her educational background includes:

• Doctor of Medicine, University of Wisconsin Medical School, 1994-1998
• Bachelor of Science with Distinction, Psychology, University of Wisconsin, 1989-1993

Dr. Burroughs specializes in developing safer bone marrow transplant procedures for children with sickle cell disease, marrow failure disorders, and inherited immune deficiencies. Her research pioneers gentler pre-transplant conditioning regimens using reduced-intensity chemotherapy and radiation to minimize treatment toxicity while maintaining efficacy. Clinically, she treats patients in Pediatric Hematology/Oncology with expertise in nonmalignant hematopoietic cell transplantation.

Her work drives multiple clinical trials including the Conditioning SCID Infants Diagnosed Early (CSIDE) phase II study and Treosulfan-based transplantation protocols for non-malignant disorders. Research trends focus on optimizing outcomes for rare pediatric immune disorders through consortium collaborations like the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Transplantation & Cellular Therapy Consortium (PTCTC), with findings featured in Hutch News coverage of innovative pediatric transplant approaches.

No scientific awards were explicitly mentioned in the source material.

Dr. Burroughs serves as principal investigator for nine active clinical trials addressing severe combined immunodeficiency (SCID), chronic granulomatous disease, and nonmalignant transplant complications. While no formal advisees are listed, her leadership in the Non-Malignant Transplant Program involves direct mentorship of clinical fellows and research staff across the Fred Hutch-Seattle Children's Hospital partnership.

She co-leads multidisciplinary teams within the Clinical Research Division at Fred Hutch, collaborating with Seattle Children's Hospital clinicians and University of Washington researchers to advance curative therapies for rare pediatric blood disorders through the Bone Marrow Transplantation Program.